Meta opted for a solution that pairs one of the biggest institutional bond firms with one of the fastest growing players in the private credit world https://t.co/evJ1vScn0r ...

The private credit arm of BC Partners has launched a new fund to succeed its $1.6 billion predecessor created through its partnership with Great Lakes to invest in middle-market deals, the firm said Tuesday https://t.co/h8hS0xET6y ...

The country lags behind when it comes to the use of private credit, which offers more flexible terms than conventional bank lending. There are, however, signs this is changing https://t.co/gN8pxjIBd4 ...

Clime Capital Limited Convertible Notes (CAM Notes) Offer - CAM Notes (ASX code: CAMG) offer a fixed interest return of 6.5% per annum, payable monthly, with a maturity date of 30 November 2028 [11] - The minimum investment is $2,000 (2,000 Notes @ $1.00 each) [11] - CAM Notes are convertible to ordinary CAM shares at $1.00 on a 1:1 basis anytime before maturity [11] - The notes are unsecured and unsubordinated, ranking behind secured creditors and equal with other unsubordinated debt [11] CAM.ASX Strategy - CAM.ASX is a Listed Investment Company equities portfolio focused on generating income above ASX 200 Dividend yield [18] - CAM.ASX leverages up to 40% of portfolio value to generate an interest margin and improve yield [18] - Clime Capital's Gross Asset Value (GAV) is $155 million as of 18 August 2025 [30] - Clime Capital (CAM.ASX) has 149 million shares on issue, with a market capitalization of $105 million and NTA (Net Tangible Assets) per share of $0.82 [30] Private Credit Market - Australia's non-bank lending sector has grown to $310 billion as of April 2025, representing approximately 8% of the total credit market of $3.93 trillion [46] - In January 2017, non-bank lending was $133 billion compared to a total credit market of $2.6 trillion [46] - The portfolio mix for credit investments is approximately 60-90% in private loans and 10-40% in liquid credit/cash [55]

Financial Data and Key Metrics Changes - SWK Holdings reported GAAP pretax net income of $4.6 million or $0.37 per diluted share for Q2 2025, with a net income of $3.5 million after tax expenses [8] - The GAAP book value per share was $20.23, an 11% decrease from $22.72 as of June 30, 2024, but adjusted for the $4 per share dividend, it was $24.46, reflecting a 6.8% year-over-year increase [9] - Non-GAAP adjusted net income for the finance segment was $4.6 million, indicating a stable run rate for the business going forward [5][12] Business Line Data and Key Metrics Changes - The finance receivables segment revenue decreased by $1.2 million year-over-year, primarily due to a $3.4 million decrease in interest and fees from paydowns and the sale of the majority of the royalty portfolio [8] - The pharmaceutical development segment revenue increased by $500,000 year-over-year [8] - Operating expenses for the finance receivables segment decreased significantly from $7.4 million in 2024 to $4.2 million in 2025, largely due to a reduction in provision for credit losses [10] Market Data and Key Metrics Changes - The company has returned $49 million to shareholders through a $4 per share dividend and an additional $3 million through share repurchases [4][5] - The remaining financial assets include $234 million in gross performing first lien term loans with an effective yield of 14.1% [5] Company Strategy and Development Direction - The company is focused on realizing the underlying value of its assets and ensuring shareholder benefits through asset sales and capital returns [4][5] - The management team aims to simplify the business structure and maintain a healthy loan book, indicating a disciplined approach to capital deployment [12] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the second quarter's results as a reasonable proxy for future earnings power, despite some expected noise in Q3 due to the transition services agreement with Aptar [12] - Concerns regarding regulatory changes, particularly from the FDA, were addressed, with management indicating minimal impact on their portfolio companies [22][23] Other Important Information - The company completed the sale of the majority of its royalty assets and the Mod three subsidiary, which was seen as a successful outcome for shareholders [4][6] - The company has been disciplined in capital deployment, with a focus on existing performing borrowers and cautious about new loans [30][31] Q&A Session Summary Question: What about the costs associated with the Mod three sale? - Management confirmed that all costs associated with Mod three have been transferred to Aptar, with no ongoing costs remaining on their side [15][16] Question: What is the impact of FDA changes on portfolio companies? - Management indicated that there are minimal concerns regarding FDA changes affecting their portfolio, as they do not have companies pending drug approvals [22][23] Question: How does the influx of private credit affect deal flow? - Management acknowledged the increased capital in the market but emphasized a disciplined approach to capital deployment, focusing on core deals and existing borrowers [30][31]

Private Credit Market Overview - Private credit executives' hope for a deal comeback was quashed in Q2 [1] - US tariffs and a prolonged deal drought stymied capital deployment in the industry [1]

Financial Transaction - KKR 牵头为 Thoma Bravo 旗下的 Flexera Software 提供约 30 亿美元的私募信贷融资方案 [1] - 该融资旨在为 Flexera Software 的现有银团贷款进行再融资并支付股息 [1] Company Information - Flexera Software 为 Thoma Bravo 旗下公司 [1]

Industry Overview & Trends - The alternatives industry has grown significantly in the last 15-16 years, becoming more institutionalized with professional management and reporting processes [2] - Private credit may see a boom in an economic downturn due to big lenders' hesitancy and favorable terms for lenders [4] - Technology-focused investments are relatively uncorrelated to macro volatility due to secular trends [5] - Access to private equity is expanding from institutional investors to high net worth individuals and potentially 401(k)s [5][6] - Liquidity is a key issue in alternatives, requiring matching investor liquidity horizons with asset durations [6][7] Market Size & Opportunities - US private equity industry is valued at $3-4 trillion, compared to $8-10 trillion in 401(k)s, highlighting the potential of accessing the 401(k) capital pool [6] - Public markets in technology have approximately 700 companies, while the private market target is 20,000 companies, indicating broader opportunities in private markets [9][10] - A significant portion (20-30 trillion) of the public market value is concentrated in a few companies (the magnificent seven), suggesting diversification benefits in private markets [10] Investment Considerations - Alternative investments can be suitable for regular accredited investors depending on their profile and percentage of exposure [8] - Investing in private markets allows access to a broader range of companies compared to public markets [10]

Small pension funds helped finance Germany's biggest property bubble in years. Now many are proving to be losers of the private credit boom https://t.co/yOUcHSrzE6 ...

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 reached $56.2 million, a 93% increase from $29.1 million in the prior year [23] - Adjusted net income increased by 87% to $21.9 million compared to $11.7 million in the prior year [26] - Adjusted EBITDA grew to $31.5 million, representing an 89% increase from $16.7 million in the prior year [26] - GAAP net income attributable to stockholders was $17.6 million, up from $0.7 million in the prior year [26] - Adjusted return on equity was 21% and adjusted return on invested capital was 22% as of June 30, 2025 [27] Business Line Data and Key Metrics Changes - Life Solutions business posted a realized gain of $58.3 million in Q2 2025, reflecting strong investor demand [12] - Asset management segment generated $8.8 million in revenue for Q2 2025, marking significant contributions from recent acquisitions [24] - New AUM inflows were approximately $142 million, contributing to a total gross AUM of nearly $3.3 billion [8] Market Data and Key Metrics Changes - The company holds 600 policies valued at $387.3 million on the balance sheet as of June 30, 2025 [24] - The annualized turnover ratio was 2.3 times in Q2 2025, above the long-term average target of 1.5 to 2 times [18] - The average realized gain on sale was 26.3% for Q2 2025, consistently above 20% over the past year and a half [21] Company Strategy and Development Direction - The company aims to position itself as a leading alternative assets and wealth management platform, focusing on less correlated investments and policyholder liquidity solutions [7] - A new $20 million share repurchase program was authorized to enhance shareholder value [14] - The company is expanding its brand recognition and wealth management offerings, which are expected to drive future growth [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate current market conditions due to its unique business model and operational acumen [11] - The full-year 2025 adjusted net income outlook was raised to between $74 million and $80 million, implying year-over-year growth of 59% to 72% [27] - Management acknowledged potential unpredictability in the overall economy but remains optimistic about continued growth in the second half of the year [49] Other Important Information - The company introduced additional key performance indicators to provide greater transparency into its business model and strategic execution [13] - The company completed an exchange offer and consent solicitation related to outstanding warrants, simplifying its capital structure [14] Q&A Session Summary Question: Can you provide specifics on the mix of sales between related party transactions and third parties? - Management indicated that related party transactions accounted for 29% of total revenue in Q2 and 17% year-to-date, including various funds [38][39] Question: What were the unrealized gains in the quarter? - Unrealized gains for the quarter were approximately $17 million, with a significant portion of the $58 million realized gains coming from prior unrealized gains [45][48] Question: How do you expect G&A expenses to trend going forward? - G&A expenses are expected to grow with revenue but not at the same percentage, with a target to be below $18 million on a quarterly basis [61] Question: What is the outlook for the second half of the year? - Management expects growth in the second half, although it may not be dollar-for-dollar compared to the first half due to economic uncertainties [49][50] Question: Is the $142 million of flows gross or net? - The $142 million was gross, with net flows being less significant due to the nature of long-term strategies [84][86]